NAYA NAYA Biosciences, Inc.

Nasdaq www.nayabiosciences.com


$ 1.08 $ 0.65 (85.68 %)    

Thursday, 16-Oct-2025 19:59:34 EDT
QQQ $ 598.23 $ -2.23 (-0.37 %)
DIA $ 458.84 $ -3.15 (-0.68 %)
SPY $ 658.90 $ -4.53 (-0.68 %)
TLT $ 91.49 $ 0.68 (0.75 %)
GLD $ 401.79 $ 9.06 (2.34 %)
$ 1.4
$ 0.75
$ 1.00 x 1
$ 1.19 x 1
$ 0.72 - $ 2.11
$ 0.68 - $ 42.48
210,807,807
na
6.11M
$ 0.99
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-20-2025 03-31-2025 10-Q
3 04-30-2025 12-31-2024 10-K
4 11-19-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 04-16-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 04-17-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
15 03-31-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
17 08-16-2021 06-30-2021 10-Q
18 05-17-2021 03-31-2021 10-Q
19 03-30-2021 12-31-2020 10-K
20 11-16-2020 09-30-2020 10-Q
21 08-13-2020 06-30-2020 10-Q
22 05-15-2020 03-31-2020 10-Q
23 03-30-2020 12-31-2019 10-K
24 11-14-2019 09-30-2019 10-Q
25 08-14-2019 06-30-2019 10-Q
26 05-15-2019 03-31-2019 10-Q
27 04-16-2019 12-31-2018 10-K
28 11-14-2018 09-30-2018 10-Q
29 08-14-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
31 03-29-2018 12-31-2017 10-K
32 11-14-2017 09-30-2017 10-Q
33 09-05-2017 03-31-2016 10-Q
34 09-05-2017 06-30-2016 10-Q
35 09-05-2017 09-30-2016 10-Q
36 08-10-2017 06-30-2017 10-Q
37 05-15-2017 03-31-2017 10-Q
38 04-20-2017 12-31-2016 10-K
39 03-17-2017 12-31-2015 10-K
40 11-21-2011 09-30-2011 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Public company to operate under new name and concentrate on building, acquiring and operating fertility clinics and the distrib...

Core News & Articles

NAYA Biosciences, Inc. ("NAYA") (NASDAQ:NAYA), a life science portfolio company dedicated to bringing breakthrough trea...

Core News & Articles

Maxim Group analyst Jason McCarthy upgrades NAYA Biosciences (NASDAQ:NAYA) from Hold to Buy and announces $2 price target.

Core News & Articles

Each Unit Consisting Of One Common Share And One Warrant; Warrants Exercisable Immediately With $0.87 Exercise Price, Expiring ...

Core News & Articles

  PD-1 x VEGF antibodies show potential to surpass checkpoint inhibitors as standard-of-care in multiple oncology indications• ...

Core News & Articles

NAYA Biosciences ("NAYA") (NASDAQ:NAYA), a life science portfolio company dedicated to bringing breakthrough treatments...

Core News & Articles

NAYA Biosciences ("NAYA") (NASDAQ:NAYA), a life science portfolio company dedicated to bringing breakthrough treatments...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION